Tumor response and survival in patients with advanced non-small-cell lung cancer: the predictive value of chemotherapy-induced changes in fibrinogen

<p>Abstract</p> <p>Background</p> <p>Hyperfibrinogenemia is a common problem associated with various carcinomas, and is accompanied by hypercoagulablity. In advanced non-small-cell lung cancer (NSCLC) it remains unclear whether or not chemotherapy-induced changes in fibrinogen level relate to chemot...

Descripció completa

Dades bibliogràfiques

Autors principals:	Zhao Jun, Zhao Mingfang, Jin Bo, Yu Ping, Hu Xuejun, Teng Yuee, Zhang Jingdong, Luo Ying, Zhang Lingyun, Zheng Shuang, Zhou Qiyin, Li Heming, Liu Yunpeng, Qu Xiujuan
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2012-08-01
Col·lecció:	BMC Cancer
Matèries:	Hyperfibrinogenemia Biomarker NSCLC
Accés en línia:	http://www.biomedcentral.com/1471-2407/12/330
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!